FDA
-
-
-
-
-
-
-
Liminal BioSciences (LMNL) Announces Signature of Share Purchase Agreement for sale of Remaining Plasma-derived Business with Kedrion
-
-
-
-
-
-
-
Liminal BioSciences Announces Closing of Divestiture of Plasma Collection Centers and Enters into Option Agreement with Kedrion
-
-
-
-
-
-
-
Liminal BioSciences Receives FDA Approval for its US-based Plasma Collection Center
-
-
-
-
-
-
-
Liminal Biosciences to Reschedule Reporting of Q3 2020 Results and Conference Call
-
-
-
-
-
-
-
Liminal BioSciences to Present at The H.C. Wainwright 22nd Annual Global Investment Conference
-
-
-
-
-
-
-
Liminal Biosciences to Present at Canaccord 40th Annual Growth Conference
-
-
-
-
-
-
-
Liminal BioSciences Provides Guidance Update on Certain Expected Key Milestones For 2020
-
251,761 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All